Cargando…

Glatiramer Acetate (Copaxone) Modulates Platelet Activation and Inhibits Thrombin-Induced Calcium Influx: Possible Role of Copaxone in Targeting Platelets during Autoimmune Neuroinflammation

BACKGROUND: Glatiramer acetate (GA, Copaxone, Copolymer-1) is an FDA approved drug for the treatment of MS and it is very effective in suppressing neuroinflammation in experimental autoimmune encephalitis (EAE), an animal model of MS. Although this drug was designed to inhibit pathogenic T cells, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Starossom, Sarah C., Veremeyko, Tatyana, Dukhinova, Marina, Yung, Amanda W. Y., Ponomarev, Eugene D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008572/ https://www.ncbi.nlm.nih.gov/pubmed/24788965 http://dx.doi.org/10.1371/journal.pone.0096256

Ejemplares similares

Demonstration of Equivalence of Generic Glatiramer Acetate and Copaxone(®)
por: Lipsky, Peter, et al.
Publicado: (2021)

Physicochemical, biological, functional and toxicological characterization of the European follow-on glatiramer acetate product as compared with Copaxone
por: Melamed-Gal, S., et al.
Publicado: (2018)

Enduring Clinical Value of Copaxone® (Glatiramer Acetate) in Multiple Sclerosis after 20 Years of Use
por: Wynn, Daniel R.
Publicado: (2019)

Assessing the In Vitro Potential of Glatiramer Acetate (Copaxone(®)) as a Chemotherapeutic Candidate for the Treatment of Cryptococcus neoformans Infection
por: Alves, Vinicius, et al.
Publicado: (2023)

Five-year outcome in the copaxone observatory: a nationwide cohort of patients with multiple sclerosis starting treatment with glatiramer acetate in France
por: Lebrun-Frenay, Christine, et al.
Publicado: (2019)

Equivalent Gene Expression Profiles between Glatopa(™) and Copaxone(®)
por: D’Alessandro, Josephine S., et al.
Publicado: (2015)

Platelets Recognize Brain-Specific Glycolipid Structures, Respond to Neurovascular Damage and Promote Neuroinflammation
por: Sotnikov, Ilya, et al.
Publicado: (2013)

Correction: Platelets Recognize Brain-Specific Glycolipid Structures, Respond to Neurovascular Damage and Promote Neuroinflammation
por: Sotnikov, Ilya, et al.
Publicado: (2014)

Prevotella histicola, A Human Gut Commensal, Is as Potent as COPAXONE® in an Animal Model of Multiple Sclerosis
por: Shahi, Shailesh K., et al.
Publicado: (2019)

A pharmacogenetic signature of high response to Copaxone in late-phase clinical-trial cohorts of multiple sclerosis
por: Ross, Colin J., et al.
Publicado: (2017)

Cyclic AMP Pathway Suppress Autoimmune Neuroinflammation by Inhibiting Functions of Encephalitogenic CD4 T Cells and Enhancing M2 Macrophage Polarization at the Site of Inflammation
por: Veremeyko, Tatyana, et al.
Publicado: (2018)

The Role of Neuronal Factors in the Epigenetic Reprogramming of Microglia in the Normal and Diseased Central Nervous System
por: Veremeyko, Tatyana, et al.
Publicado: (2019)

Neuronal extracellular microRNAs miR‐124 and miR‐9 mediate cell–cell communication between neurons and microglia
por: Veremeyko, Tatyana, et al.
Publicado: (2018)

Follow-on glatiramer acetate
por: Cohen, Jeffrey A., et al.
Publicado: (2018)

Neuroprotective Effect of Combination Therapy of Glatiramer Acetate and Epigallocatechin-3-Gallate in Neuroinflammation
por: Herges, Katja, et al.
Publicado: (2011)

Response to the Letter-to-the Editor by Cohen et al. concerning our eNeurologicalSci article, Melamed-Gal, et al. Physicochemical, biological, functional and toxicological characterization of the European follow-on glatiramer acetate product as compared with Copaxone. eNeurologicalSci 2018;12:19–30.https://doi.org/10.1016/j.ensci.2018.05.006
por: Melamed-Gal, Sigal, et al.
Publicado: (2018)

CD8(+) T Cells Are Required For Glatiramer Acetate Therapy in Autoimmune Demyelinating Disease
por: Tyler, Andrew F., et al.
Publicado: (2013)

Glatiramer acetate in the treatment of multiple sclerosis
por: Tselis, Alex, et al.
Publicado: (2007)

IL-4/IL-13-Dependent and Independent Expression of miR-124 and Its Contribution to M2 Phenotype of Monocytic Cells in Normal Conditions and during Allergic Inflammation
por: Veremeyko, Tatyana, et al.
Publicado: (2013)

STUDIES ON THROMBIN-INDUCED PLATELET AGGLUTINATION
por: Shermer, Richard W., et al.
Publicado: (1961)

Platelet thrombin receptor antagonism and atherothrombosis
por: Angiolillo, Dominick J., et al.
Publicado: (2010)

Early Growth Response Gene-2 Is Essential for M1 and M2 Macrophage Activation and Plasticity by Modulation of the Transcription Factor CEBPβ
por: Veremeyko, Tatyana, et al.
Publicado: (2018)

Corrigendum: Early Growth Response Gene-2 Is Essential for M1 and M2 Macrophage Activation and Plasticity by Modulation of the Transcription Factor CEBPβ
por: Veremeyko, Tatyana, et al.
Publicado: (2018)

Platelet-activating factor enhancement of calcium influx and interleukin-6 expression, but not production, in human microglia
por: Sattayaprasert, Prasongchai, et al.
Publicado: (2005)

Suilysin-induced Platelet-Neutrophil Complexes Formation is Triggered by Pore Formation-dependent Calcium Influx
por: Zhang, Shengwei, et al.
Publicado: (2016)

Thrombin-induced events in non-platelet cells are mediated by the unique proteolytic mechanism established for the cloned platelet thrombin receptor
Publicado: (1992)

Delineating Zinc Influx Mechanisms during Platelet Activation
por: Kuravi, Sahithi J., et al.
Publicado: (2023)

Complement C4-deficient mice have a high mortality rate during PTZ-induced epileptic seizures, which correlates with cognitive problems and the deficiency in the expression of Egr1 and other immediate early genes
por: Veremeyko, Tatyana, et al.
Publicado: (2023)

Transport and storage of serotonin by thrombin-treated platelets
Publicado: (1975)

Metabolic Plasticity in Resting and Thrombin Activated Platelets
por: Ravi, Saranya, et al.
Publicado: (2015)

Fatal dysfunction and disintegration of thrombin-stimulated platelets
por: Kim, Oleg V., et al.
Publicado: (2019)

Impact of Edoxaban on Thrombin-Dependent Platelet Aggregation
por: Sokol, Juraj, et al.
Publicado: (2020)

Thrombin generation abnormalities in Quebec platelet disorder
por: Brunet, Justin G., et al.
Publicado: (2020)

The role of glatiramer acetate in the early treatment of multiple sclerosis
por: Brandes, David W
Publicado: (2010)

Spasticity in multiple sclerosis and role of glatiramer acetate treatment
por: Meca-Lallana, Jose Eustasio, et al.
Publicado: (2015)

Glatiramer Acetate-associated Refractory Immune Thrombocytopenic Purpura
por: Sagy, Iftach, et al.
Publicado: (2016)

Physicochemical and Biological Examination of Two Glatiramer Acetate Products
por: Komlosh, Arthur, et al.
Publicado: (2019)

Bullous pemphigoid as an injection site reaction of glatiramer acetate
por: Baghbanian, Seyed Mohammad, et al.
Publicado: (2019)

Glatiramer Acetate Immunomodulation: Evidence of Neuroprotection and Cognitive Preservation
por: Kasindi, Arielle, et al.
Publicado: (2022)

An Immunomodulatory Peptide Dendrimer Inspired from Glatiramer Acetate
por: Erzina, Dina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p5ng328p8ku0161av47eqjjo3d